191 related articles for article (PubMed ID: 32442222)
61. Intestinal inflammation in cystic fibrosis.
Smyth RL; Croft NM; O'Hea U; Marshall TG; Ferguson A
Arch Dis Child; 2000 May; 82(5):394-9. PubMed ID: 10799435
[TBL] [Abstract][Full Text] [Related]
62. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
Walkowiak J; Sands D; Nowakowska A; Piotrowski R; Zybert K; Herzig KH; Milanowski A
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):199-201. PubMed ID: 15699697
[TBL] [Abstract][Full Text] [Related]
63. Gut virome sequencing in children with early islet autoimmunity.
Kramná L; Kolářová K; Oikarinen S; Pursiheimo JP; Ilonen J; Simell O; Knip M; Veijola R; Hyöty H; Cinek O
Diabetes Care; 2015 May; 38(5):930-3. PubMed ID: 25678103
[TBL] [Abstract][Full Text] [Related]
64. Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction.
Mack DR; Flick JA; Durie PR; Rosenstein BJ; Ellis LE; Perman JA
J Pediatr; 1992 May; 120(5):696-701. PubMed ID: 1578303
[TBL] [Abstract][Full Text] [Related]
65. Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease.
Fernandes MA; Verstraete SG; Phan TG; Deng X; Stekol E; LaMere B; Lynch SV; Heyman MB; Delwart E
J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):30-36. PubMed ID: 30169455
[TBL] [Abstract][Full Text] [Related]
66. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.
Zhao G; Vatanen T; Droit L; Park A; Kostic AD; Poon TW; Vlamakis H; Siljander H; Härkönen T; Hämäläinen AM; Peet A; Tillmann V; Ilonen J; Wang D; Knip M; Xavier RJ; Virgin HW
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6166-E6175. PubMed ID: 28696303
[TBL] [Abstract][Full Text] [Related]
67. Severe disease in Cystic Fibrosis and fecal calprotectin levels.
Parisi GF; Papale M; Rotolo N; Aloisio D; Tardino L; Scuderi MG; Di Benedetto V; Nenna R; Midulla F; Leonardi S
Immunobiology; 2017 Mar; 222(3):582-586. PubMed ID: 28012584
[TBL] [Abstract][Full Text] [Related]
68. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years.
Ellemunter H; Engelhardt A; Schüller K; Steinkamp G
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):438-442. PubMed ID: 28207476
[TBL] [Abstract][Full Text] [Related]
69. Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis.
Beaufils F; Mas E; Mittaine M; Addra M; Fayon M; Delhaes L; Clouzeau H; Galode F; Lamireau T; Bui S; Enaud R
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33348735
[TBL] [Abstract][Full Text] [Related]
70. Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children.
Mathew S; Smatti MK; Al Ansari K; Nasrallah GK; Al Thani AA; Yassine HM
Sci Rep; 2019 Jan; 9(1):865. PubMed ID: 30696865
[TBL] [Abstract][Full Text] [Related]
71. Urogenital abnormalities in male children with cystic fibrosis.
Blau H; Freud E; Mussaffi H; Werner M; Konen O; Rathaus V
Arch Dis Child; 2002 Aug; 87(2):135-8. PubMed ID: 12138064
[TBL] [Abstract][Full Text] [Related]
72. Viruses in cystic fibrosis patients' airways.
Billard L; Le Berre R; Pilorgé L; Payan C; Héry-Arnaud G; Vallet S
Crit Rev Microbiol; 2017 Nov; 43(6):690-708. PubMed ID: 28340310
[TBL] [Abstract][Full Text] [Related]
73. Body image and dieting behavior in cystic fibrosis.
Truby H; Paxton AS
Pediatrics; 2001 Jun; 107(6):E92. PubMed ID: 11389290
[TBL] [Abstract][Full Text] [Related]
74. Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children.
Kapur N; Mackay IM; Sloots TP; Masters IB; Chang AB
Arch Dis Child; 2014 Aug; 99(8):749-53. PubMed ID: 24819370
[TBL] [Abstract][Full Text] [Related]
75. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.
Henderson WR; Astley SJ; McCready MM; Kushmerick P; Casey S; Becker JW; Ramsey BW
J Pediatr; 1994 Mar; 124(3):400-8. PubMed ID: 8120709
[TBL] [Abstract][Full Text] [Related]
76. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
[TBL] [Abstract][Full Text] [Related]
77. [Concentration of plasma beta-carotene in cystic fibrosis children with pancreatic insufficiency].
Laskowska-Klita T; Chełchowska M
Med Wieku Rozwoj; 2002; 6(3):267-72. PubMed ID: 12637781
[TBL] [Abstract][Full Text] [Related]
78. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls.
Greer RM; Buntain HM; Potter JM; Wainwright CE; Wong JC; O'Rourke PK; Francis PW; Bell SC; Batch JA
Osteoporos Int; 2003 Jun; 14(5):404-11. PubMed ID: 12730764
[TBL] [Abstract][Full Text] [Related]
79. Comparison of Nasal Potential Difference and Intestinal Current Measurements as Surrogate Markers for CFTR Function.
Wilschanski M; Yaakov Y; Omari I; Zaman M; Martin CR; Cohen-Cymberknoh M; Shoseyov D; Kerem E; Dasilva D; Sheth S; Uluer A; OʼSullivan BP; Freedman S
J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e92-e97. PubMed ID: 27496797
[TBL] [Abstract][Full Text] [Related]
80. Energy expenditure and genotype of children with cystic fibrosis.
Tomezsko JL; Stallings VA; Kawchak DA; Goin JE; Diamond G; Scanlin TF
Pediatr Res; 1994 Apr; 35(4 Pt 1):451-60. PubMed ID: 7519343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
